Maintaining sterility for therapeutics that biopharmaceutical and cell and gene manufacturers produce is critical – particularly when unique, personalized samples are processed for precision medicine. As precision medicine grows, so does the demand for greater efficiencies in smaller batch aseptic manufacturing.
Nik Ekman, Application Development Manager at CPC, makes the case for moving outside of the biosafety cabinet. The white paper focuses on:
MicroCNX sterile connectors are proven to deliver flexibility, ease of use, less downtime and increased reliability and cost efficiencies, which can make them a better choice for system designers and processors.
In Episode 2 hosted by Nik Ekman, Application Development Manager for CPC Biopharma, he invites Fred Parietti, Co-founder of Multiply Labs to discuss automation and robotics in cell therapy manufacturing.
Learn about cryopreservation challenges, best practices and the latest advances in single-use products, including the new MicroCNX® Nano Series connectors, which are made to meet the rigorous demands of today’s CGT processes.